Mar 3
|
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
|
Feb 14
|
Institutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year losses
|
Feb 13
|
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
|